Flamm B L, Goings J R, Fuelberth N J, Fischermann E, Jones C, Hersh E
Department of Obstetrics and Gynecology, Kaiser Permanente Medical Centers, California.
Obstet Gynecol. 1987 Nov;70(5):709-12.
The use of oxytocin for labor induction or augmentation in patients with previous cesarean delivery is controversial. This paper presents a series of 1776 patients allowed to labor after a previous cesarean section, of whom 485 (27%) were treated with oxytocin. When the patients who received oxytocin were compared with those who did not, no significant differences were found with respect to uterine rupture, maternal morbidity, fetal morbidity, or fetal mortality. We conclude that the judicious use of oxytocin is safe in the patient with a previous low transverse cesarean section.
对于有剖宫产史的患者使用缩宫素引产或加强宫缩存在争议。本文报告了1776例有剖宫产史后允许经阴分娩的患者,其中485例(27%)接受了缩宫素治疗。将接受缩宫素治疗的患者与未接受治疗的患者进行比较,发现在子宫破裂、母体发病率、胎儿发病率或胎儿死亡率方面无显著差异。我们得出结论,对于既往有低位横切口剖宫产史的患者,谨慎使用缩宫素是安全的。